Freeline Therapeutics Shares Resume Trading
Portfolio Pulse from Benzinga Newsdesk
Shares of Freeline Therapeutics have resumed trading.

July 14, 2023 | 6:29 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Freeline Therapeutics' shares have resumed trading.
The resumption of trading for a company's shares doesn't inherently indicate a positive or negative impact on the stock price. It simply means that the shares are available for trading again. Therefore, the score is neutral.
CONFIDENCE 100
IMPORTANCE 50
RELEVANCE 100